文献速递脊柱外科

单节段与双节段腰椎全椎间盘置换术后1至21年临床结局:1187例患者随访

Clinical Outcomes After 1 and 2-Level Lumbar Total Disc Arthroplasty: 1,187 Patients with 7 to 21-Year Follow-up.
PubMed 文献 · J Bone Joint Surg Am · 2024-11-22

研究纳入1999至2013年接受腰椎全椎间盘置换术的1187例慢性腰椎退行性椎间盘疾病患者,其中772例单节段、415例双节段,373例(31.4%)有既往同节段手术史。随访7至21年(平均11年8个月),所有组ODI在术后3个月大幅下降并维持,术后24个月各组疼痛缓解无显著差异;全组49例(4.13%)需新节段手术或翻修/再手术,翻修率与邻近节段手术率分别0.67%和1.85%。结论认为单节段与双节段置换、既往手术与无既往手术患者改善等效。

要点

  • 单节段与双节段腰椎全椎间盘置换术后7至21年ODI和疼痛评分均大幅且持续改善。
  • 术后24个月各组疼痛缓解无显著差异,既往手术组VAS下降速度较慢但最终水平无差异。
  • 全组翻修率0.67%、邻近节段手术率1.85%,49例(4.13%)需再手术或翻修。

核心结论

  • 单节段与双节段腰椎全椎间盘置换术后7至21年临床成功稳健,残疾与疼痛评分大幅且持续下降,翻修/再手术率及邻近节段手术率相对已发表的长期融合数据较低。
  • 单节段与双节段置换患者改善等效,既往同节段手术与无既往手术患者改善亦等效。

研究设计与样本

  • 1999至2013年纳入1187例慢性腰椎退行性椎间盘疾病接受腰椎全椎间盘置换术患者,其中772例单节段、415例双节段,373例(31.4%)有既往同节段手术史。
  • 随访7至21年(平均11年8个月),评估影像学、神经学、体格检查及ODI和腰腿痛VAS,并记录围手术期数据、并发症率及再手术/翻修率。
  • 患者分为4组:单节段无既往手术、单节段有既往手术、双节段无既往手术、双节段有既往手术。
  • 证据等级:治疗性III级。

主要发现

  • 所有组术后3个月ODI大幅下降并随时间维持。
  • 既往手术组VAS疼痛下降至最终水平的速度较慢,但术后24个月各组间疼痛缓解无显著差异。
  • 1187例中49例(4.13%)需其他节段新手术或同节段翻修/再手术,各组发生率均太低无法进行统计学比较。
  • 7至21年全椎间盘置换翻修率为0.67%,邻近节段手术率为1.85%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In this study, we expand the supportive evidence for total disc arthroplasty (TDA) with results up to 21 years in a large patient cohort who received a semiconstrained ball-and-socket lumbar prosthesis. The objectives of the study were to compare the results for 1 versus 2-level surgeries and to evaluate whether prior surgery at the index level(s) impacts clinical outcomes. METHODS: From 1999 to 2013, 1,187 patients with chronic lumbar degenerative disc disease (DDD) underwent lumbar TDA, of whom 772 underwent a 1-level procedure and 415 underwent a 2-level procedure. A total of 373 (31.4%) of the 1,187 patients had prior index-level surgery. Patients were evaluated preoperatively; at 3, 6, 12, 18, and 24 months postoperatively; and yearly thereafter. The follow-up duration ranged from 7 to 21 years (mean, 11 years and 8 months). Collected data included radiographic, neurological, and physical assessments, as well as self-evaluations using the Oswestry Disability Index (ODI) and visual analog scale (VAS) for back and leg pain. Perioperative data points, complication rates, and reoperation or revision rates were also assessed. Patients were divided into 4 groups: 1-level TDA with no prior surgery at the index level, 1-level TDA with prior surgery, 2-level TDA with no prior surgery, and 2-level TDA with prior surgery. RESULTS: All groups showed dramatic reduction in the ODI at 3 months postoperatively and maintained these scores over time. Although VAS pain did not diminish to its final level as rapidly for patients with prior surgery, there was no significant difference between the groups in terms of pain reduction at 24 months postoperatively. Of 1,187 patients, 49 (4.13%) required either a new surgery at another level or revision or reoperation at the index level. Rates were too low in all groups to compare them statistically. Total TDA revision and adjacent-level surgery rates over 7 to 21 years were very low (0.67% and 1.85%, respectively). CONCLUSIONS: This study demonstrates the robust long-term clinical success of 1 and 2-level lumbar TDA as assessed at 7 to 21 years postoperatively in one of the largest evaluated cohorts of patients with TDA. Patients had dramatic and maintained reductions in disability and pain scores over time and low rates of index-level revision or reoperation and adjacent-level surgery relative to published long-term fusion data. Additionally, patients who underwent 1-level lumbar TDA and those who underwent 2-level TDA demonstrated equivalent improvement, as did patients with prior surgery at the index level and those with no prior surgery. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Marnay TP, Geneste GY, Edgard-Rosa GW, et al. Clinical Outcomes After 1 and 2-Level Lumbar Total Disc Arthroplasty: 1,187 Patients with 7 to 21-Year Follow-up. J Bone Joint Surg Am. 2024. PMID: 40100011. doi:10.2106/JBJS.23.00735

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。